About Anocca

Anocca is a Swedish privately funded biotech company with a primary focus on developing technologies, diagnostics and therapeutic strategies for individualized management of oncological, autoimmune and inflammatory conditions through harnessing adaptive immunity.

At the core of Anocca is a proprietary immunotechnology platform that enables immunotherapeutic target discovery, validation and product development in a clinical setting where individualized patient assessment and tailored solutions are defining. This technological platform is integrated with high-performance manufacturing strategies within state of the art GMP facilities that have been approved by the Swedish Medical Products Agency.


Facility contact

Forskargatan 20
151 36 Södertälje
+46 (0)8 410 807 50
Show on map

For information

+46 8 410 807 58